ACSO — Accesso Technology Group plc

Executive summary

Accesso is a vertical SaaS/transaction platform for leisure venues (theme parks, ski resorts, museums, live entertainment) providing ticketing, distribution, virtual queuing, POS, and — post-Dexibit — an "AI Intelligence" analytics layer to over 1,100 clients in 31 countries. Across 2021–2026 the trajectory shows a post-COVID snap-back to ~$155m revenue (FY25), followed by flatlining growth (FY26 guidance $146m) as virtual-queuing contract changes with two major customers, macro-driven attendance softness, and a delayed Saudi Horizon rollout offset progress in ticketing/eCommerce and cross-sell of accesso Freedom/Intelligence 2026-03 FY25 results, 2026-09 H1. The single most important valuation point is that ACSO is a decent-quality vertical SaaS on ~14–15% Cash EBITDA margins with a modest-to-flat growth engine, priced at a mid-single-digit EV/Cash EBITDA multiple — fair rather than cheap once you adjust for the aggressive Cash EBITDA definition (which adds back share-based payments and acquisition costs).

Fair value estimate

Range: 280p – 380p per share · Implied mcap: £91m – £123m

Methodology: blended (i) forward P/E on FY26 adjusted EPS and (ii) EV/Cash EBITDA multiple on FY26 guidance, cross-checked to peers.

• FY26 guidance: revenue ~$146m, Cash EBITDA ~$20m 2026-09 H1
• FY25 adjusted basic EPS 44.26c ≈ 33p at $/£ 1.29; FY26 adjusted EPS likely 35–42c on lower revenue and margin gains from cost actions
• Applying 9–12x forward adjusted EPS ≈ 280–380p per share
• EV/Cash EBITDA: 7–9x × $20m ≈ $140–180m EV; less adjusted net debt ~$0.5m → mcap $140–180m ≈ £108–140m at $/£ 1.29
• Reasonability: statutory operating profit was only $14.4m FY25 and $1.0m H1 26 — Cash EBITDA overstates cash generation because it adds back $4.2m share-based payments and does not fully reflect $25m of drawn debt post-tender

vs. £100.1m current mcap: -9% downside to +23% upside; midpoint ~£107m ≈ +7%. View: fair.

Sector context

Confirmed: Technology / vertical SaaS. ACSO is a small-cap AIM specialist software business. Growth (low-single-digit), gross margin (~78%) and net-cash-to-modestly-levered balance sheet put it in line with typical UK vertical SaaS peers but well below the growth profile of premium US comps. Listed peers of relevance: Gentrack (GTK.L, utilities vertical SaaS), Cerillion (CER.L, telco billing SaaS), and internationally Vivaticket / Booking-adjacent players; in ticketing specifically Vivaticket (private) and Booking.com/Ticketmaster are indirect adjacencies rather than pure comps.

Investment thesis

• High recurring revenue mix and mission-critical positioning — 84.4% of H1 26 revenue is "repeatable", predominantly transactional % of ticket sales; the business sits at the point where money moves through a venue, and switching costs are high. Two operators drive >10% of revenue each with long-standing agreements 2026-03 FY25 results.
• AI-first ecosystem strategy with early cross-sell traction — the March 2026 Dexibit acquisition brought a purpose-built AI analytics layer (100+ integrations); five customers signed post-acquisition with a pipeline of ~100 opportunities. Payments (accessoPay via Adyen) went live in H1 26, opening a new revenue stream and mid-market TAM expansion 2026-09 H1.
• Disciplined capital allocation and shareholder returns at what management believes is undervalued price — $15.9m FY25 buyback plus $20m tender at 300p in March 2026, cancelling 18.9% of issued share capital since April 2025. Refinanced $40m HSBC RCF to 2030 at improved pricing 2026-03 FY25 results, 2026-09 H1.

Key risks

• Revenue growth has stalled and virtual queuing is in decline — H1 26 group revenue -0.2% YoY; Guest Experience -41.7% as two major customers exited/renegotiated virtual queuing contracts. Middle East milestone-based Horizon revenue continues to slip (~$0.5m already deferred into 2027) 2026-09 H1.
• Statutory profitability weak vs. adjusted metrics; balance sheet has tightened — H1 26 statutory PBT was $0.3m vs. $1.9m PY; adjusted net cash swung from +$21.6m at Dec 2025 to -$0.5m at Jun 2026 after tender + Dexibit. Cash EBITDA add-backs (share-based payments $4.2m, acquisition costs $1.3m) meaningfully overstate underlying cash generation 2026-09 H1.
• AI positioning is more marketing than moat, and the sector is being reshaped — Dexibit brings only ~$1.4m ARR and 40 customers; competitors are also embedding AI features. Customers explicitly delaying tech decisions to assess AI options has lengthened sales cycles. Structural risk that operators reduce transactional-revenue-share when facing AI-enabled alternatives 2026-09 H1, inferred.

Operating leverage

Accesso has moderate operating leverage. Gross margin is ~78% (89% ex-distribution pass-through), and the cost base is dominated by ~617 staff and R&D — largely fixed at any given plan level. Underlying admin expenditure was $99.5m in FY25 vs. $155m revenue, meaning theoretically 78% of incremental revenue should drop through gross profit. In practice, H1 26 demonstrated this: revenue was flat, admin cost fell 6.1% via headcount reduction, and Cash EBITDA jumped 49.7% ($5.1m → $7.6m) with margin from 7.5% → 11.2% 2026-09 H1. On a 15% revenue upside ($22m over $146m guide), if gross margin holds at 78%, ~$17m would flow through gross profit against a largely flat cost base — potentially adding 60–80% to Cash EBITDA. However, transactional revenue is volume-linked (attendance-driven), so the "surprise" revenue tends to be lower-margin ticketing and distribution, not high-margin licences. The inflection point that matters is Intelligence and payments cross-sell converting — these carry near-zero incremental cost and would drop almost entirely to profit.

Value-trap signals

• Revenue flat-to-declining ex-currency for three years despite acquisition roll-ups (VGS/Horizon, Paradox, Dexibit)
• Persistent gap between adjusted and statutory earnings — adjusted EPS 44.26c FY25 vs. basic EPS 27.96c
• CEO succession (Steve Brown → Lee Cowie May 2026) mid-strategic transition
• Two customers >10% of revenue each = customer concentration risk (already materialised in virtual queuing)
• Aggressive Cash EBITDA definition adding back significant SBC ($4.2m) — the primary quoted metric flatters vs. peers using EBITDA
• Falling headcount (689 → 617) partly reflects operating discipline but also constrained investment capacity
• Prolonged sales cycles as customers "assess AI options" — pattern of guidance revisions downward (Aug 2024, Jan 2026)

Earnings vs. expectations

Pattern across the period is more misses/downgrades than beats. FY24 revenue guidance was cut in Aug 2024 from ~$160m to $150–153m; FY24 outturn was $152.3m at 1.9% growth (with unfavourable mix). FY25 came in $155m — slightly ahead of the reduced $146m consensus but Cash EBITDA margin ~15% was ahead of the 13–14% guided range. FY26 guidance ($146m revenue, $20m Cash EBITDA) reflects further downgrades from the previous $155m base after two major virtual queuing contracts changed. On the positive side, H1 26 Cash EBITDA of $7.6m exceeded H1 25 by 49.7% via cost discipline. Overall pattern: management sets ambitious topline, revises down mid-year, then delivers on the reduced margin bar.

Conviction

Conviction: 3 (moderate)

Anchors: (a) disclosures are clean, IFRS-audited with clear alt-perf reconciliations; (b) two distinct valuation methods (P/E and EV/Cash EBITDA) converge on a similar range; (c) the business model is well-understood vertical SaaS.

Limits: (a) the gap between statutory and adjusted profitability is wide and Cash EBITDA definition is aggressive — the "right" multiple depends heavily on which metric you anchor to; (b) the Intelligence/payments cross-sell is early and represents the main upside case but has minimal disclosed revenue contribution to underwrite.